| Thomas Herrera, MD | |
|
23621 Se H K Dodgen Loop, Temple, TX 76504-8664 | |
| (254) 410-0555 | |
| (870) 424-3089 |
| Full Name | Thomas Herrera |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 7 Years |
| Location | 23621 Se H K Dodgen Loop, Temple, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609300797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | T3968 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wright Medical Consulting Pllc | 5698104354 | 3 |
News Archive
In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real - and are increasing drastically."
Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.
5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Ärzteblatt International, Alfons Meindl of the Klinikum rechts der Isar and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes.
AstraZeneca today announced the presentation of important new data from studies of FASLODEX (fulvestrant) Injection at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium taking place from 4-8 December at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood.
› Verified 4 days ago
| Entity Name | Wright Medical Consulting Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306470646 PECOS PAC ID: 5698104354 Enrollment ID: O20200331002197 |
News Archive
In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real - and are increasing drastically."
Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.
5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Ärzteblatt International, Alfons Meindl of the Klinikum rechts der Isar and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes.
AstraZeneca today announced the presentation of important new data from studies of FASLODEX (fulvestrant) Injection at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium taking place from 4-8 December at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Herrera, MD 860 Highway 62 E Ste 10, Mountain Home, AR 72653-3200 Ph: (870) 424-3181 | Thomas Herrera, MD 23621 Se H K Dodgen Loop, Temple, TX 76504-8664 Ph: (254) 410-0555 |
News Archive
In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real - and are increasing drastically."
Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.
5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Ärzteblatt International, Alfons Meindl of the Klinikum rechts der Isar and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes.
AstraZeneca today announced the presentation of important new data from studies of FASLODEX (fulvestrant) Injection at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium taking place from 4-8 December at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood.
› Verified 4 days ago
Dr. John David R. Seno, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 Fax: 254-724-7603 | |
Armando Castillo, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1901 Veterans Memorial Dr, Temple, TX 76504 Phone: 254-778-4811 | |
Mrs. Mariah Ann Graupmann Hunter, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 706 Red Coat Dr, Temple, TX 76504 Phone: 254-742-1581 | |
Dr. Paul D. Lemper, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. William G. Stanley, D.O. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Kevin Gates, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Thomas K. Joseph, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |